tiprankstipranks
Trending News
More News >

Shineco Completes Acquisition of InfiniClone Limited

Story Highlights
Shineco Completes Acquisition of InfiniClone Limited

Don’t Miss TipRanks’ Half-Year Sale

An update from Shineco ( (SISI) ) is now available.

On June 18, 2025, Shineco Life Science Group Hong Kong Co., Limited, a subsidiary of Shineco, Inc., completed the acquisition of 51% equity in InfiniClone Limited, a Hong Kong-based company. This strategic acquisition, valued at approximately $19.9 million in cash and 3,450,000 shares of Shineco’s common stock, positions Shineco Life Science to expand its operations and strengthen its market presence in the biotechnology sector.

More about Shineco

Shineco, Inc. operates in the life sciences industry through its subsidiary Shineco Life Science Group Hong Kong Co., Limited, focusing on biotechnology and related services.

Average Trading Volume: 1,493,443

Technical Sentiment Signal: Strong Sell

Current Market Cap: $6.64M

See more data about SISI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1